Single treatment with cisplatin or UFT, but not their combination treatment enhances the metastatic capacity of mouse fibrosarcoma cells.
第一作者:
S,Choi
第一单位:
Laboratory of Pathology, Cancer Institute, Hokkaido University School of Medicine, Sapporo, Japan.
作者:
医学主题词
动物(Animals);抗肿瘤联合化疗方案(Antineoplastic Combined Chemotherapy Protocols);趋化作用(Chemotaxis);顺铂(Cisplatin);克隆细胞(Clone Cells);复方合剂(Drug Combinations);抗药性, 肿瘤(Drug Resistance, Neoplasm);女(雌)性(Female);纤维肉瘤(Fibrosarcoma);半数抑制浓度(Inhibitory Concentration 50);小鼠(Mice);小鼠, 近交C57BL(Mice, Inbred C57BL);肿瘤侵润(Neoplasm Invasiveness);RNA, 信使(RNA, Messenger);RNA, 肿瘤(RNA, Neoplasm);喃氟啶(Tegafur);金属蛋白酶1组织抑制剂(Tissue Inhibitor of Metalloproteinase-1);肿瘤细胞, 培养的(Tumor Cells, Cultured);尿嘧啶(Uracil)
DOI
10.1097/00001813-199902000-00013
PMID
10211555
发布时间
2019-09-15
- 浏览16
Anti-cancer drugs
235-43页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文


换一批



